Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response

Pseudomonas aeruginosa Phenotypes Associated With Eradication Failure in Children With Cystic Fibrosis

(2014) Nicole Mayer-Hamblett et al.   CLINICAL INFECTIOUS DISEASES

Twenty-Five-Year Outbreak of Pseudomonas aeruginosa Infecting Individuals with Cystic Fibrosis: Identification of the Prairie Epidemic Strain

(2014) M. D. Parkins et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Impact of Air Pollution on Cystic Fibrosis Pulmonary Exacerbations

(2013) Pieter C. Goeminne et al.   CHEST

Systematic Review of Blood Biomarkers in Cystic Fibrosis Pulmonary Exacerbations

(2013) Alborz Hakimi Shoki et al.   CHEST

Comparison of real time diagnostic chemistries to detect Pseudomonas aeruginosa in respiratory samples from cystic fibrosis patients

(2013) J.L. Fothergill et al.   Journal of Cystic Fibrosis

Molecular analysis of changes in Pseudomonas aeruginosa load during treatment of a pulmonary exacerbation in cystic fibrosis

(2013) D.W. Reid et al.   Journal of Cystic Fibrosis

The role of respiratory viruses in adult patients with cystic fibrosis receiving intravenous antibiotics for a pulmonary exacerbation

(2013) C. Etherington et al.   Journal of Cystic Fibrosis

Inflammation and Airway Microbiota during Cystic Fibrosis Pulmonary Exacerbations

(2013) Edith T. Zemanick et al.   PLoS One

Phenotypic Heterogeneity of Pseudomonas aeruginosa Populations in a Cystic Fibrosis Patient

(2013) Matthew L. Workentine et al.   PLoS One

Is the Improvement of CF Patients, Hospitalized for Pulmonary Exacerbation, Correlated to a Decrease in Bacterial Load?

(2013) Pieter Deschaght et al.   PLoS One

Microbiota and Metabolite Profiling Reveal Specific Alterations in Bacterial Community Structure and Environment in the Cystic Fibrosis Airway during Exacerbation

(2013) Kate B. Twomey et al.   PLoS One

Blood mRNA biomarkers for detection of treatment response in acute pulmonary exacerbations of cystic fibrosis

(2013) J A Nick et al.   THORAX

How the airway smooth muscle in cystic fibrosis reacts in proinflammatory conditions: implications for airway hyper-responsiveness and asthma in cystic fibrosis

(2013) Sarah McCuaig et al.   Lancet Respiratory Medicine

Multiple antibiotic-resistant Pseudomonas aeruginosa and lung function decline in patients with cystic fibrosis

(2012) Clement L. Ren et al.   Journal of Cystic Fibrosis

Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: A comparative efficacy trial

(2012) Baroukh M. Assael et al.   Journal of Cystic Fibrosis

Factors associated with a shorter time until the next pulmonary exacerbation in adult patients with cystic fibrosis

(2012) Iara Maria Sequeiros et al.   Chronic Respiratory Disease

Pseudomonas aeruginosaPopulation Diversity and Turnover in Cystic Fibrosis Chronic Infections

(2011) Eilidh Mowat et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Incidence and Risk Factors for Pulmonary Exacerbation Treatment Failures in Patients With Cystic Fibrosis Chronically Infected With Pseudomonas aeruginosa

(2011) Michael D. Parkins et al.   CHEST

Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis

(2011) Valerie Waters et al.   EUROPEAN RESPIRATORY JOURNAL

Pulmonary exacerbation: Towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials

(2011) D. Bilton et al.   Journal of Cystic Fibrosis

Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation?

(2011) Franziska A. Stressmann et al.   Journal of Cystic Fibrosis

Adherence with tobramycin inhaled solution and health care utilization

(2011) Becky A Briesacher et al.   BMC Pulmonary Medicine

Failure to Recover to Baseline Pulmonary Function after Cystic Fibrosis Pulmonary Exacerbation

(2010) Don B. Sanders et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

McKay agar enables routine quantification of the 'Streptococcus milleri' group in cystic fibrosis patients

(2010) C. D. Sibley et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Return of FEV1after pulmonary exacerbation in children with cystic fibrosis

(2010) Don B. Sanders et al.   PEDIATRIC PULMONOLOGY

Respiratory Microbiology of Patients With Cystic Fibrosis in the United States, 1995 to 2005

(2009) Samiya Razvi et al.   CHEST

Inhaled Aztreonam Lysine for Chronic AirwayPseudomonas aeruginosain Cystic Fibrosis

(2008) Karen S. McCoy et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

TheStreptococcus milleri group—An unrecognized cause of disease in cystic fibrosis: A case series and literature review

(2008) Michael D. Parkins et al.   PEDIATRIC PULMONOLOGY

A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients

(2008) C. D. Sibley et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA